Prevention of cardiovascular diseases in breast cancer survivors
- سال انتشار: 1394
- محل انتشار: یازدهمین کنگره بین المللی سرطان پستان
- کد COI اختصاصی: ICBCMED11_056
- زبان مقاله: انگلیسی
- تعداد مشاهده: 449
نویسندگان
Department of Medical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Department of Medical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Department of Medical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Department of Medical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
چکیده
One of the main causes of death in women is breast cancer. Breast cancer survivors due to toxicities of therapies, particularly anthracycline chemotherapy, left-sided radiotherapy, and trastuzumab targeted therapy are at increased risk of cardiovascular disease-related death. Critical and initial step of cardiovascular diseases such as atherosclerosis is activation of endothelial cells (ECs). Early detection and rapid regeneration of damaged endothelial cells will be having a very important role in preventing of atherosclerosis. We synthesized peptide- targeted fluorescein isothiocyanate (FITC) - loaded Poly (DL-lactic-co-glycolic acid) nanoparticles (PLGA NPs) directed against vascular cell adhesion molecule 1 (VCAM-1) for targeting therapeutic and imaging agents to ECs in inflammatory sites for early detection and rapid regeneration of damaged endothelial cells. FITC- loaded PLGA NPs were synthesized by using double-nozzle electrospraying and conjugated with a peptide antagonist of very late antigen- 4 by ) by 1-Ethyl- 3-[3-dimethylaminopropyl] carbodiimide hydrochloride / N-hydroxysuccinimide (EDC/NHS) as coupling agents. Results of fluorescence microscopy showed that the targeted FITC-loaded NPs are rapidly endocytosis to a greater extent than the untargeted FITC-loaded NPs. Therefore targeted PLGA NPs may have therapeutic and diagnosis applications in prevention of cardiovascular diseases in breast cancer survivors.کلیدواژه ها
VCAM-1; PLGA NPs; Endothelial cells, breast cancerمقالات مرتبط جدید
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.